Research Analysts Offer Predictions for Medifast Q2 Earnings

Medifast, Inc. (NYSE:MED) – Equities research analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for Medifast in a note issued to investors on Monday, November 25th. Zacks Research analyst A. Mohta now anticipates that the specialty retailer will earn $0.29 per share for the quarter, down from their previous estimate of $0.37. The consensus estimate for Medifast’s current full-year earnings is $1.51 per share. Zacks Research also issued estimates for Medifast’s Q3 2025 earnings at $0.34 EPS, Q4 2025 earnings at $0.38 EPS, Q1 2026 earnings at $0.42 EPS and Q2 2026 earnings at $0.43 EPS.

Medifast (NYSE:MED) last released its quarterly earnings results on Monday, November 4th. The specialty retailer reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.50. The business had revenue of $140.16 million during the quarter, compared to analyst estimates of $135.45 million. Medifast had a return on equity of 15.98% and a net margin of 1.09%. During the same quarter last year, the company posted $2.12 EPS.

Separately, DA Davidson raised Medifast from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $16.50 to $17.00 in a research note on Tuesday, November 5th.

Medifast Stock Up 6.1 %

MED stock opened at $19.44 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.11 and a quick ratio of 2.55. The firm has a market capitalization of $212.67 million, a P/E ratio of 29.45 and a beta of 1.13. Medifast has a 52-week low of $17.07 and a 52-week high of $76.42. The company’s 50 day simple moving average is $18.50 and its 200-day simple moving average is $19.82.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. nVerses Capital LLC lifted its holdings in Medifast by 54.5% in the 2nd quarter. nVerses Capital LLC now owns 1,700 shares of the specialty retailer’s stock worth $37,000 after purchasing an additional 600 shares during the last quarter. Quarry LP lifted its stake in shares of Medifast by 592.7% in the second quarter. Quarry LP now owns 2,667 shares of the specialty retailer’s stock worth $58,000 after buying an additional 2,282 shares during the last quarter. CWM LLC grew its stake in Medifast by 370.8% in the 2nd quarter. CWM LLC now owns 4,684 shares of the specialty retailer’s stock valued at $102,000 after buying an additional 3,689 shares during the last quarter. Swedbank AB bought a new position in Medifast in the 1st quarter worth $115,000. Finally, Public Employees Retirement System of Ohio raised its holdings in Medifast by 1,161.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock worth $187,000 after acquiring an additional 8,992 shares during the period. Institutional investors and hedge funds own 95.51% of the company’s stock.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.